Clinical Trial Update: Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating LBH589B in adult patients with refractory chronic myeloid leukemia in accelerated or blast phase; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• LBH589B

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Leukemia, Myeloid, Chronic | Phase 2 | Status: TERMINATED | Results posted: 2021-07-14